Alvesco FDA Approval History

FDA Approved: Yes (First approved January 10, 2008)
Brand name: Alvesco
Generic name: ciclesonide
Dosage form: Inhalation Aerosol
Company: Nycomed
Treatment for: Asthma

Alvesco (ciclesonide) is an inhaled corticosteroid indicated for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.

Development timeline for Alvesco

Date	Article
Jan 16, 2008	Approval Alvesco Gains FDA Approval for the U.S. Market
Oct 26, 2004	Aventis Receives Approvable Letter from U.S. Food and Drug Administration for Alvesco (ciclesonide) for Treatment of Persistent Asthma
Jan 1, 2004	Aventis Submits New Drug Application to FDA for Asthma Drug Alvesco (ciclesonide)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Approval History Drug history at FDA

WADA Class Anti-Doping Classification

Alvesco FDA Approval History

Development timeline for Alvesco

See also

Further information